Ken Fisher's TNGX Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 578,158 shares of Tango Therapeutics, Inc. (TNGX) worth $18.07 M, representing 0.01% of the portfolio. First purchased in 2023-Q4, this medium-term investment has been held for 11 quarters.
Based on 13F filings, Ken Fisher has maintained a strategic position in TNGX, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2026, adding 415,759 shares. Largest reduction occurred in Q1 2026, reducing 25,294 shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's Tango Therapeutics (TNGX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Tango Therapeutics (TNGX) Trades by Ken Fisher
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +415,759 | Add 256.01% | 578,158 | $31.26 |
| Q1 2026 | -25,294 | Reduce 13.48% | 162,399 | $20.92 |
| Q4 2025 | -22,659 | Reduce 10.77% | 187,693 | $8.86 |
| Q3 2025 | -13,725 | Reduce 6.13% | 210,352 | $8.40 |
| Q1 2025 | +69,130 | Add 44.62% | 224,077 | $1.37 |
| Q2 2024 | +54,256 | Add 53.88% | 154,947 | $8.58 |
| Q4 2023 | +100,691 | New Buy | 100,691 | $9.90 |
Ken Fisher's Tango Therapeutics Investment FAQs
Ken Fisher first purchased Tango Therapeutics, Inc. (TNGX) in Q4 2023, acquiring 100,691 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held Tango Therapeutics, Inc. (TNGX) for 11 quarters since Q4 2023.
Ken Fisher's largest addition to Tango Therapeutics, Inc. (TNGX) was in Q2 2026, adding 578,158 shares worth $18.07 M.
According to the latest 13F filing for Q2 2026, Ken Fisher's firm, Fisher Asset Management, LLC, owns 578,158 shares of Tango Therapeutics, Inc. (TNGX), valued at approximately $18.07 M.
As of the Q2 2026 filing, Tango Therapeutics, Inc. (TNGX) represents approximately 0.01% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings.
Ken Fisher's peak holding in Tango Therapeutics, Inc. (TNGX) was 578,158 shares, as reported at the end of Q2 2026.